2024 Legal Secretaries & Administrators Conference

May 21 to 22, 2024

Location

VIRTUAL

Contact

Registration

Fee: FREE - Registration Required
Registration closes May 20, 2024 at 5:30 PM

Register Now

Increase Your Expertise in Navigating USPTO Operations 

It can be hard to stay on top of the latest news, procedures, and tools. The Legal Secretaries and Administrators conference can assist. This conference is designed for paralegals, administrators, and other office specialists to hear directly from the United States Patent and Trademark Office (USPTO). This two-day virtual program provides a comprehensive overview of new features and services, best practices for streamlining procedures, and opportunities to ask questions and hear directly from the USPTO.

 

This program is presented by AIPLA and the USPTO. This event is a key resource to keep you up-to-date on operational matters at the Office and may assist you in your everyday tasks and responsibilities. 

 

 

Will include presentations from the following USPTO organizations:

Office of Information Technology for Patents (OITP)
Office of Patent Application Processing (OPAP)
Office of Data Management (ODM)
Office of Patent Legal Administration (OPLA)
Office of Administrative Services (OAS): Assignment Recordation Branch (ARB)
Office of Petitions (OPET)
Office of the Commissioner for Trademarks (TM)
Office of International Patent Cooperation (OIPC): International Patent Legal Administration (IPLA)
Office of International Patent Cooperation (OIPC): International Outreach and Administration (IOA)
Office of Patents Stakeholder Experience (OPSE)

Add to:

 

 

News

  • Washington DC web AIPLA Comments on the OECD's Working Party on Countering Illicit Trade (WP-CIT) Draft Voluntary Guidelines

    August 27, 2025

    Arlington, VA. August 25, 2025 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on the OECD’s Draft Voluntary Guidelines for Countering Illicit Trade in Counterfeit Goods on Online Marketplaces, highlighting best practices for governments, online marketplace operators, and rights holders.
  • Legislation (1) web Letter of Support - S. 2667 / H.R. 4930 - Customs Info Sharing Authority

    August 13, 2025

    Arlington, VA. August 13, 2025-The American Intellectual Property Law Association (AIPLA) submitted a joint letter with a coalition of organizations representing thousands of American businesses, including many leading global brands, to Senators Grassley, Hassan, and Representatives Moore, and Schneider expressing strong support for S. 2677 / H.R. 4930. The letter highlights the growing threat of counterfeit and pirated goods entering U.S. borders, urges enhanced cooperation between public and private sectors, and commends the legislation for clarifying U.S. Customs and Border Protection’s authority to share information and expand collaboration with key stakeholders to improve intellectual property enforcement.
  • TermDisc-Comments-March21-logo AIPLA Comments on the UPC Mediation and Arbitration Centre’s Draft Mediation Rules

    July 22, 2025

    Arlington, VA. July 21, 2025 – The American Intellectual Property Law Association (AIPLA) submitted comments to the UPC Mediation and Arbitration Centre (PMAC) regarding its proposed Mediation Rules.
  • Senate web AIPLA Submits Letter to US Senate Judiciary Committee on Squires Nomination to the USPTO

    June 16, 2025

    Arlington, VA. June 11, 2025 –The American Intellectual Property Law Association (AIPLA) submitted a letter in response to the nomination of John A. Squires as Director of the United States Patent & Trademark Office (“USPTO”). In view of his impressive background, AIPLA believes Mr. Squires is fully capable of undertaking this important role and appreciates the Senate Judiciary Committee giving this nominee prompt consideration.
  • TermDisc-Comments-March21-logo AIPLA Comments on Draft NMPA Measures

    June 9, 2025

    Arlington, VA. May 17, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the National Medical Products Administration’s (NMPA) draft measures on the protection of drug trial data in China.